1. Home
  2. RDHL vs FGI Comparison

RDHL vs FGI Comparison

Compare RDHL & FGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • FGI
  • Stock Information
  • Founded
  • RDHL 2009
  • FGI 1987
  • Country
  • RDHL Israel
  • FGI United States
  • Employees
  • RDHL N/A
  • FGI N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • FGI Industrial Specialties
  • Sector
  • RDHL Health Care
  • FGI Industrials
  • Exchange
  • RDHL Nasdaq
  • FGI Nasdaq
  • Market Cap
  • RDHL 3.8M
  • FGI 5.5M
  • IPO Year
  • RDHL N/A
  • FGI 2022
  • Fundamental
  • Price
  • RDHL $2.03
  • FGI $0.72
  • Analyst Decision
  • RDHL
  • FGI
  • Analyst Count
  • RDHL 0
  • FGI 0
  • Target Price
  • RDHL N/A
  • FGI N/A
  • AVG Volume (30 Days)
  • RDHL 19.2K
  • FGI 143.0K
  • Earning Date
  • RDHL 04-10-2025
  • FGI 08-06-2025
  • Dividend Yield
  • RDHL N/A
  • FGI N/A
  • EPS Growth
  • RDHL N/A
  • FGI N/A
  • EPS
  • RDHL N/A
  • FGI N/A
  • Revenue
  • RDHL $8,042,999.00
  • FGI $134,277,102.00
  • Revenue This Year
  • RDHL $381.91
  • FGI $7.72
  • Revenue Next Year
  • RDHL N/A
  • FGI $6.94
  • P/E Ratio
  • RDHL N/A
  • FGI N/A
  • Revenue Growth
  • RDHL 23.17
  • FGI 11.13
  • 52 Week Low
  • RDHL $1.71
  • FGI $0.46
  • 52 Week High
  • RDHL $20.28
  • FGI $1.20
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 57.04
  • FGI 54.58
  • Support Level
  • RDHL $1.75
  • FGI $0.64
  • Resistance Level
  • RDHL $2.08
  • FGI $0.67
  • Average True Range (ATR)
  • RDHL 0.09
  • FGI 0.07
  • MACD
  • RDHL 0.03
  • FGI 0.00
  • Stochastic Oscillator
  • RDHL 85.16
  • FGI 43.59

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About FGI FGI Industries Ltd.

FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.

Share on Social Networks: